<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Second Sight Medical Products, Inc. EYES (&#34;Second Sight&#34; or 
 &#34;the Company&#34;), a developer, manufacturer and marketer of implantable 
 visual prosthetics to provide some useful vision to blind patients, 
 today announced the Argus II® Retinal Prosthesis System ("Argus 
 II") can now be covered by Medicare in seven of the 12 Medicare 
 Administrative Contractor ("MAC") jurisdictions nationwide, representing 
 a total of 28 states, two territories, and the District of 
 Columbia.
 
 
 The MAC for jurisdictions JH and JL, Novitas Solutions, Inc. ("Novitas") 
 published a local coverage determination removing the Category III 
 Current Procedural Terminology Code that describes the Argus II 
 placement procedure (0100T) from the listing of codes that are 
 considered not reasonable and necessary. This decision authorizes 
 coverage of Argus II, when medically necessary, to Medicare 
 beneficiaries in Arkansas, Colorado, Delaware, Louisiana, Maryland, 
 Mississippi, New Jersey, New Mexico, Oklahoma, Pennsylvania, Texas, and 
 the District of Columbia.
 
 
 By allowing Medicare coverage for Argus II, Novitas joins MACs CGS 
 Administrators (jurisdiction J15), Palmetto GBA (jurisdiction JM), 
 National Government Services (jurisdictions J6 and JK), and First Coast 
 Service Options (jurisdiction JN).
 
 
 Will McGuire, President and CEO of Second Sight, said, "We are pleased 
 that Novitas has made this important decision to facilitate coverage of 
 the Argus II, which we believe will enable us to offer greater access to 
 patients with Retinitis Pigmentosa and continue to fulfill our mission 
 of providing useful vision to the blind."
 
 
 Second Sight continues to work with other MACs and payers to secure 
 affirmative coverage policies for the Argus II and to ensure that 
 Medicare beneficiaries nationwide have access to this revolutionary 
 technology.
 
 
 About the Argus II Retinal Prosthesis System
 
 
 Second Sight&#39;s Argus II System provides electrical stimulation that 
 bypasses the defunct retinal cells and stimulates remaining viable cells 
 inducing visual perception in individuals with severe to profound 
 Retinitis Pigmentosa. The Argus II works by converting images captured 
 by a miniature video camera mounted on the patient&#39;s glasses into a 
 series of small electrical pulses, which are transmitted wirelessly to 
 an array of electrodes implanted on the surface of the retina. These 
 pulses stimulate the retina&#39;s remaining cells, intending to result in 
 the perception of patterns of light in the brain. The patient must learn 
 to interpret these visual patterns, having the potential to regain some 
 visual function. The Argus II was the first artificial retina to receive 
 widespread approval, and is offered at approved centers in Canada, 
 France, Germany, Italy, Saudi Arabia, Spain, Taiwan, Turkey, United 
 Kingdom, and the U.S.
 
 
 About Second Sight
 
 
 Second Sight&#39;s mission is to develop, manufacture and market innovative 
 implantable visual prosthetics to enable blind individuals to achieve 
 greater independence. Second Sight has developed and manufactures the 
 Argus® II Retinal Prosthesis System. Second Sight is currently 
 conducting a trial to test the safety and utility of the Argus II in 
 individuals with Dry Age-Related Macular Degeneration. Second Sight is 
 also developing the Orion™ I Visual Cortical Prosthesis that is intended 
 to restore some vision to individuals who are blind due to many causes 
 other than preventable or treatable conditions. U.S. Headquarters are in 
 Sylmar, CA, and European Headquarters are in Lausanne, Switzerland. For 
 more information, visit <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.secondsight.com&amp;esheet=51583351&amp;newsitemid=20170703005086&amp;lan=en-US&amp;anchor=www.secondsight.com&amp;index=1&amp;md5=b9d897c9355b39e1f0ee26c9e3592ab6" rel="nofollow" rel="nofollow">www.secondsight.com</a>.
 
 
 Safe Harbor
 
 
 This press release contains forward-looking statements within the 
 meaning of Section 27A of the Securities Act of 1933, as amended, and 
 Section 21E of the Securities Exchange and Exchange Act of 1934, as 
 amended, which are intended to be covered by the &#34;safe harbor&#34; created 
 by those sections. All statements in this release that are not based on 
 historical fact are &#34;forward looking statements.&#34; These statements may 
 be identified by words such as &#34;estimates,&#34; &#34;anticipates,&#34; &#34;projects,&#34; 
 &#34;plans,&#34; or &#34;planned,&#34; &#34;seeks,&#34; &#34;may,&#34; &#34;will,&#34; &#34;expects,&#34; &#34;intends,&#34; 
 &#34;believes,&#34; &#34;should&#34; and similar expressions or the negative versions 
 thereof and which also may be identified by their context. All 
 statements that address strategies, estimated size of potential markets, 
 anticipated expansion of MAC coverage, operating performance or events 
 or developments that Second Sight expects or anticipates will occur in 
 the future, or that are not otherwise historical facts, are 
 forward-looking statements. While management has based any forward 
 looking statements included in this release on its current expectations, 
 the information on which such expectations were based may change. 
 Forward-looking statements involve inherent risks and uncertainties 
 which could cause actual results to differ materially from those in the 
 forward-looking statements, as a result of various factors including 
 those risks and uncertainties described in the Risk Factors and in 
 Management&#39;s Discussion and Analysis of Financial Condition and Results 
 of Operations sections of our Annual Report on Form 10-K as filed 
 on March 16, 2017, and our other reports filed from time to time with 
 the Securities and Exchange Commission. We urge you to consider those 
 risks and uncertainties in evaluating our forward-looking statements. We 
 caution readers not to place undue reliance upon any such 
 forward-looking statements, which speak only as of the date made. Except 
 as otherwise required by the federal securities laws, we disclaim any 
 obligation or undertaking to publicly release any updates or revisions 
 to any forward-looking statement contained herein (or elsewhere) to 
 reflect any change in our expectations with regard thereto or any change 
 in events, conditions or circumstances on which any such statement is 
 based.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170703005086r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170703005086/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170703005086/en/</a></body></html>

Press Releases

Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia 

EYES

Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia

FULT


Fulton doubles regional presence while providing stability to customers


Fulton Financial Corporation (NASDAQ:FULT) (the &#34;Corporation&#34;) today announced that its bank subsidiary, Fulton Bank, N.A. (&#34;Fulton&#34;), has

Fulton Financial Corporation Acquires Substantially All of the Assets and Assumes Substantially All of the Deposits of Republic First Bank From the FDIC


In response to the unprecedented challenges that Latin America has faced during various health crises such as AH1N1, Zika, COVID-19, and Dengue, a prominent group of former health ministers and public health academics

Latin America CDC a Must, say Public Health Leaders and AHF

DOOR


Owens Corning (NYSE:OC), a leader in global building and construction materials, and Masonite International Corporation (&#34;Masonite&#34;) (NYSE:DOOR), a leading global provider of interior and exterior doors and door

Owens Corning and Masonite Extend Early Participation Deadline and Announce Successful Results of Early Participation in Tender Offer and Consent Solicitation

USMT


US Metro Bancorp (OTCQX:USMT): US Metro Bancorp (&#34;Bancorp&#34;) is a bank holding company, with a single subsidiary, US Metro Bank (&#34;Bank&#34;). On a consolidated basis, the Bancorp earned $1.5 million in the first quarter of

US Metro Bancorp Announces First Quarter 2024 Results

DESP


Despegar.com, Corp. (NYSE:DESP), (&#34;Despegar&#34; or the &#34;Company&#34;), Latin America&#39;s leading travel technology company, today announced that its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 was

Despegar Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2023

FFIE


Faraday Future Intelligent Electric Inc. (&#34;Faraday Future&#34; or the &#34;Company&#34;) (NASDAQ:FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that it received a letter